1177888

Andrew Rezvani, M.D. — FEI 3022952263

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 19, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Palo Alto, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance